Global /South Korea /Healthcare /Drug Manufacturers - Specialty & Generic /357230

H.PIO Co., Ltd.

357230

• KRX: 357230 • Delayed

2,535KRW -0.2%

1.68 USD

As of 18 June 2026, H.PIO Co., Ltd. has a market cap of $68.6M USD, ranking #28231 globally and #1491 in South Korea. It ranks #2553 in the Healthcare sector, and #139 in the Drug Manufacturers - Specialty & Generic industry.

Global Rank

28231

Country Rank

1491

Sector Rank

2553

Industry Rank

139

Key Stats

Market Cap

$68.6MUSD

104.64B KRW

Enterprise Value

$72.88MUSD

110.0B KRW

Revenue (TTM)

$169.27MUSD

258.19B KRW

EBITDA (TTM)

$14.2MUSD

21.44B KRW

Net Income (TTM)

$5.52MUSD

8.42B KRW

EBITDA Margin

8.3%

Profit Margin

3.3%

PE Ratio

12.4

PS Ratio

0.4

PB Ratio

0.5

EV/EBITDA

5.1

Company Profile

Country (HQ)

South Korea

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

Founded

2012

Website

denps.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-0.2%	-2.3%	4.8%	-0.8%	-1.9%	4.8%	-3.2%	-30%	-73%

News

Markets

Exchange	Ticker	Price	Quotes
Korea Exchange (KRX) MIC: XKRX PRIMARY	357230 H.PIO Co Ltd ISIN: KR7357230002 Shares Out.: Shares Outstanding: 41.289M¹ Shares Float: 10.621M² TV: TradingView: KRX: 357230 SA: Stock Analysis: KRX: 357230 YF: Yahoo Finance: 357230.KS GF: Google Finance: KRX: 357230 BA: Barron's: 357230 MS: Morningstar: XKRX: 357230	2,535 KRW	TV: TradingView: KRX: 357230 SA: Stock Analysis: KRX: 357230 YF: Yahoo Finance: 357230.KS GF: Google Finance: KRX: 357230 BA: Barron's: 357230 MS: Morningstar: XKRX: 357230

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About H.PIO Co., Ltd.

H.PIO Co., Ltd., a health and lifestyle company, develops, manufactures, and sells health functional foods under the Denps brand worldwide. It offers lactic acid bacteria, vitamins, etc. The company was founded in 2012 and is headquartered in Seoul, South Korea.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (South Korea)

Name	Market Cap (USD) diff.	PE	Country
Myung In Pharmaceutical LTD. KRX: 317450	$541.76M 826.36B KRW 690%	8.4	South Korea
FutureChem Co.,Ltd KRX: 220100	$279.45M 426.25B KRW 307%	-	South Korea
KOLMAR BNH Co.,Ltd. KRX: 200130	$219.63M 335.01B KRW 220%	-	South Korea
Kwang Dong Pharmaceutical Co., Ltd. KRX: 009290	$204.29M 311.61B KRW 198%	16.3	South Korea
NOVAREX Co.,Ltd. KRX: 194700	$168.04M 256.31B KRW 145%	7.4	South Korea
Kyung Dong Pharmaceutical Co., Ltd. KRX: 011040	$99.27M 151.41B KRW 45%	17.8	South Korea

Industry: Drug Manufacturers - Specialty & Generic (Global)

Name	Market Cap (USD) diff.	PE	Country
Teva Pharmaceutical Industries Ltd. TLV: TEVA	$37.2B 108.92B ILS 54K%	24.2	Israel
Revolution Medicines, Inc. NASDAQ: RVMD	$29.56B 43K%	-	United States
Zhejiang NHU Company Ltd. SHE: 002001	$15.88B 107.34B CNY 23K%	16.0	China
Cipla Ltd. NSE: CIPLA	$11.25B 1.06T INR 16K%	23.4	India
Lupin Ltd. NSE: LUPIN	$11.13B 1.05T INR 16K%	22.7	India
Haisco Pharmaceutical Group Co., Ltd. SHE: 002653	$9.11B 61.6B CNY 13K%	80.6	China

chevron_leftBack